Cell cycle kinetics responses of human stomach cancer cells to reduction in polyamine levels by treatment with αDifluoromethylornithine in vitro
- 1 December 1986
- journal article
- research article
- Published by Springer Nature in Investigational New Drugs
- Vol. 4 (4) , 347-357
- https://doi.org/10.1007/bf00173507
Abstract
Treatment of human gastric cancer clones in vitro with low doses of DFMO (5 mM) produced elongation of the cell population doubling times and lowering of the saturation densities. By contrast, DFMO treatment of normal human skin fibroblasts altered only the saturation density. The lack of an effect of 5 mM DFMO on the doubling time of normal fibroblasts may be directly related to baseline intracellular putrescine levels, which were about 2.5 times higher than in the cancer cells. The same dose of DFMO caused a rapid decrease in intracellular polyamine levels in the tumor clones. The effects on the doubling time and saturation density were almost totally abolished by the addition of 50 μM putrescine to the growth medium during the first 24 h of treatment with DFMO. Exposure to 5 mM DFMO for 24 h caused the human gastric cancer cells to become blocked in G1 phase only, and this led to a reduction in the fraction of cells in S phase. The G1 block was reversible and this cohort of cells eventually passed through S phase and then through G2 and M. A higher 100 mM dose of DFMO and longer exposure times for both doses produced cell cycle changes and death of more than 90% of the cell population. These data suggest that cell kinetics changes observed under these experimental conditions may reflect polyamine-related alterations in the biochemical events of cell cycle progression kinetics; but may also be the result of DFMO-induced loss of cell viability.Keywords
This publication has 16 references indexed in Scilit:
- Heterogeneous survival responses of human gastric cancer clones to αDifluoromethylornithine in vitroInvestigational New Drugs, 1986
- Activation of ornithine decarboxylase in monolayer cells treated with trypsinJournal of Cellular Physiology, 1985
- Spermidine Requirement for Cell Proliferation in Eukaryotic Cells: Structural Specificity and QuantitationScience, 1983
- Ornithine Decarboxylase: Essential in Proliferation But Not Differentiation of Human Promyelocytic Leukemia CellsScience, 1982
- Synergistic action of two polyamine antimetabolites leads to a rapid therapeutic response in childhood leukemiaInternational Journal of Cancer, 1981
- Depletion of 9L rat brain tumor cell polyamine content by treatment with -?-difluoromethylornithine inhibits proliferation and the G1 to S transitionExperimental Cell Research, 1981
- Inhibition of EMT6 tumor growth by interference with polyamine biosynthesis ; Effects of α-difluoromethyl- ornithine, an irreversible inhibitor or ornithine decarboxylaseLife Sciences, 1980
- Anti-proliferative properties of DL-α-difluoromethyl ornithine in cultured cells. A consequence of the irreversible inhibition of ornithine decarboxylaseBiochemical and Biophysical Research Communications, 1978
- Effect of methylglyoxal-bis (guanylhydrazone), an inhibitor of spermidine and spermine synthesis, on cell cycle traversePublished by Elsevier ,1977
- STUDIES ON UNBALANCED GROWTH IN ESCHERICHIA COLIProceedings of the National Academy of Sciences, 1954